Photodynamic treatment of melanoma cells using aza-dipyrromethenes as photosensitizers

Photochem Photobiol Sci. 2020 Jul 1;19(7):885-891. doi: 10.1039/d0pp00114g. Epub 2020 Jun 17.

Abstract

In this study, we report for the first time the use of four aza-dipyrromethenes (ADPMs) as photosensitizers for cancer PDT. The synthesis and characterization of the ADPMs and their photodynamic action against B16F10 melanoma cells were assessed. ADPM 2 is the best singlet oxygen generator and the most phototoxic (at 2.5 μM) towards B16F10 cells.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Aza Compounds / chemical synthesis
  • Aza Compounds / chemistry
  • Aza Compounds / pharmacology*
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Mice
  • Molecular Structure
  • Photochemotherapy*
  • Photosensitizing Agents / chemical synthesis
  • Photosensitizing Agents / chemistry
  • Photosensitizing Agents / pharmacology*
  • Porphobilinogen / analogs & derivatives*
  • Porphobilinogen / chemical synthesis
  • Porphobilinogen / chemistry
  • Porphobilinogen / pharmacology
  • Structure-Activity Relationship
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Aza Compounds
  • Photosensitizing Agents
  • dipyrromethene
  • Porphobilinogen